Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

Event Details

Agios at Citi’s 16th Annual Biopharma Virtual Conference: Benign Hematology Panel Discussion

Sep 10, 2021 at 12:30 PM EDT

Webcast Presentation

Title
Agios at Citi’s 16th Annual Biopharma Virtual Conference: Benign Hematology Panel Discussion
Date / Time
Sep 10, 2021 at 12:30 PM EDT